February 10, 2022
Via: ScienceDailyThe COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the base of its spike protein that is found also on closely related coronaviruses, according to a new study from Scripps Research. The discovery, published Feb 8 in Science Translational Medicine, […]
October 6, 2021
Via: Healthcare DiveFor the past several months, one of the many questions hanging over the booster debate has ben what do with people who got J&J’s shot. The company’s application, and the FDA’s planned meeting, creates a timeline for answering that question. […]
April 13, 2021
Via: CNBCMore than a dozen states took steps Tuesday to halt inoculations with Johnson & Johnson’s coronavirus vaccine, shortly after the Food and Drug Administration recommended to pause its use after reports some women developed a rare blood clotting disorder. The […]
March 23, 2021
Via: Modern HealthcareAstraZeneca’s release Monday of encouraging data about its coronavirus vaccine from its U.S. trial raised hopes that the drug company could put a troubled rollout behind it. But just hours after its announcement, American officials issued an unusual statement expressing […]
November 18, 2020
Via: CNBCHealth-care workers in the United States could get the first doses of a coronavirus vaccine in about a month. Pfizer announced Wednesday that it planned to submit an application to the Food and Drug Administration for emergency use “within days” […]
November 16, 2020
Via: CNBCModerna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing Covid-19 — a result CEO Stephane Bancel called a “game changer.” The analysis evaluated 95 confirmed Covid-19 infections among the trial’s 30,000 […]
October 8, 2020
Via: CNBCHealth and Human Services Secretary Alex Azar said Thursday the U.S. could have enough Covid-19 vaccine doses for every American as early as March, a more optimistic estimate than President Donald Trump has publicly said. The Trump administration’s coronavirus vaccine […]
August 19, 2020
Via: MedPageTodayPatients hospitalized with mild COVID-19 in China exhibited a wide range of SARS-CoV-2-specific neutralizing antibodies, with a minority of patients with levels below the detectable limit of the assay, researchers found. Out of 175 patients, 30% developed SARS-CoV-2-specific neutralizing antibody […]
July 27, 2020
Via: ForbesThe Covid-19 vaccine candidate made by the biotech company Moderna, Inc. and developed in collaboration with the National Institutes of Health begins Phase 3 clinical trials on Monday, the first such final-phase testing trial of a coronavirus vaccine in the […]
May 7, 2020
Via: CNBCRepurposing existing drugs will be a quicker way to tackle the coronavirus pandemic than developing a vaccine, scientists have argued. In a paper published Thursday in the British Journal of Pharmacology, a team of international experts said that while there […]
May 4, 2020
Via: CNBCA vaccine for Covid-19 will not be ready until the end of next year, according to Dale Fisher, chair of the World Health Organization (WHO) Global Outbreak Alert and Response Network. That timeline would be a “very reasonable” expectation because […]
March 17, 2020
Via: CNBCThe race is on to develop an immunization against COVID-19. Dozens of companies and public labs around the world are working to develop a vaccine to prevent the spread of the flu-like virus. Over the last 48 hours, three biotech […]
March 11, 2020
Via: medicaldevice-network.comAs cases of the novel coronavirus continue to soar around the globe with no cure yet available, efforts continue to develop a protective coronavirus vaccine. While unlikely to be completed within the coming months, and therefore unlikely to be helpful […]
February 20, 2020
Via: ForbesThe new coronavirus disease, COVID-19, that originated in Wuhan, China, at the end of 2019, is poised to become a global pandemic. As of February 19, 2020, more than 75,600 people around the world have contracted the disease; 2,122 people, […]
January 31, 2020
Via: ForbesThe world needs an anti coronavirus drug as soon as possible—and there is something the United States government can do right now to achieve that. STAT News recently reported that most big pharma companies have been reluctant to join the […]
January 29, 2020
Via: CNBCThe chief executive of Novartis believes it will take at least 12 months to find a new vaccine to treat the coronavirus, with the fast-spreading nature of the outbreak a threat that must be taken “really seriously.” China’s National Health […]